Picture of Sun Pharmaceutical Industries logo

SUNPHARMA — Sun Pharmaceutical Industries News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Sun Pharma - Us FDA Accepts SBLA For Ilumya For Active Psoriatic Arthritis

March 16 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:

SUN PHARMA - US FDA ACCEPTS SBLA FOR ILUMYA FOR ACTIVE PSORIATIC ARTHRITIS

SUN PHARMA - FDA REGULATORY ACTION DATE FOR THIS SBLA IS EXPECTED BY OCT 29 2026

Source text: ID:nBSE9fxgD

Further company coverage: SUN.NS

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Sun Pharmaceutical Industries

See all news